Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$5.83−0.18 (-3.08%)
Close on Nov 18, 2026Market cap $108.99MP/E –Yield –
Trinity Biotech market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Trinity Biotech's market cap was $108.11M on Nov 11, 2026, against $563.09M a year earlier. Over the last 5 years it ranged from $108.11M to $786.71M, with a median of $350.25M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $108.11M | -74.6% |
| 2025 | Dec 31, 2025 | $426.23M | +110.8% |
| 2024 | Dec 31, 2024 | $202.16M | -21.0% |
| 2023 | Dec 29, 2023 | $255.96M | -6.8% |
| 2022 | Dec 30, 2022 | $274.69M | -32.2% |
| 2021 | Dec 31, 2021 | $404.90M | -86.1% |
| 2020 | Dec 31, 2020 | $2.91B | +262.8% |
| 2019 | Dec 31, 2019 | $802.33M | -56.6% |
| 2018 | Dec 31, 2018 | $1.85B | -57.4% |
| 2017 | Dec 29, 2017 | $4.33B | -23.9% |
| 2016 | Dec 30, 2016 | $5.69B | – |
See a number that looks wrong?